TL;DR
This systematic review synthesizes recent EEG research in Parkinson's Disease (PD), revealing specific spectral and event-related potential (ERP) patterns linked to cognitive and motor symptoms. These findings highlight EEG's potential as a diagnostic biomarker, though the precise mechanisms connecting gait and cognition remain elusive.
What Problem Does This Paper Address?
Parkinson's Disease (PD) is a complex neurodegenerative disorder characterized by both motor and non-motor symptoms, significantly impacting patients' quality of life. While the degeneration of dopaminergic neurons is the root cause, understanding the intricate interplay between motor impairments (like tremor, postural instability, and gait issues) and cognitive decline (including executive dysfunction and attention deficits) is crucial for effective diagnosis and treatment. Traditional neuroimaging methods often require patients to be in constrained environments. Electroencephalography (EEG), a non-invasive technique that captures real-time brain activity, offers a promising avenue for studying these dynamic changes in more naturalistic settings. However, a comprehensive understanding of how specific EEG characteristics relate to the diverse symptoms of PD is still needed to unlock its full potential as a diagnostic and therapeutic tool.
Methods
This paper employs a systematic review methodology to synthesize existing research on EEG characterization in Parkinson's Disease. The authors followed a PICO (Population, Intervention, Comparison, Outcome) search strategy. They systematically searched three major databases: PubMed, Web of Science, and EMBASE, for literature published between January 2010 and June 2020. The search terms combined "Parkinson's disease" with "EEG" or "Electroencephalography" and "dual task" or "cognition and motor" or "cognitive and motor." Inclusion criteria focused on full-text, English-language articles using scalp EEG to study cognitive and/or motor symptoms in PD patients. Studies on other neurological diseases, review articles, and those involving only healthy participants were excluded. A targeted search of bibliographies of relevant articles was also conducted to identify additional relevant papers. Ultimately, 30 papers were selected for inclusion in the review.
Datasets
The paper does not introduce new datasets. Instead, it analyzes and synthesizes findings from 30 previously published studies that utilized various datasets of Parkinson's Disease patients and, in many cases, healthy controls for comparison. The demographic characteristics and clinical scores of PD patients from these included studies are summarized in Table 1.
Key Insights and Ideas
- EEG as a Window into PD Brain Dynamics: EEG, particularly with advancements in mobile and real-time analysis, is emerging as a powerful, non-invasive tool to study brain activity in PD patients during naturalistic movements.
- Spectral Signatures of PD Symptoms: Specific frequency bands in EEG show distinct correlations with PD symptoms. Abnormalities in the beta (β) band are strongly linked to dyskinesia, while delta (δ) and theta (θ) bands are more indicative of cognitive decline.
- Event-Related Potentials (ERPs) as Cognitive Markers: ERPs, especially the P300 component, are sensitive to attention and cognitive function. Changes in P300 amplitude and latency in PD patients can reflect cognitive decline and attention deficits, potentially serving as a biomarker.
- The Complex Link Between Gait and Cognition: While studies show a relationship between cognitive function and motor symptoms like gait impairment (especially freezing of gait - FOG), the underlying neural mechanisms are still unclear. This lack of understanding hinders the development of targeted interventions.
- Potential for Biomarker Development: The consistent patterns observed in EEG spectral characteristics and ERPs suggest their potential utility as diagnostic biomarkers for PD, aiding in early detection and monitoring of disease progression and treatment efficacy.
Key Results
The review identified that PD patients exhibit noteworthy changes in specific EEG characteristics compared to healthy controls. Key findings include:
- Spectral Analysis:
- PD patients often show a general slowing of global EEG activity.
- A decrease in beta (β) and gamma (γ) band power is observed, while an increase in theta (θ) and alpha (α) band power is related to cognitive processes.
- Specifically, β band abnormalities are a primary indicator of dyskinesia, and δ band abnormalities are linked to cognitive decline.
- Studies suggest that the global relative median power (GRMP) of low-frequency bands can predict cognitive decline.
- Event-Related Potentials (ERPs):
- Changes in P300 ERPs (specifically P3a and P3b) are associated with attention and cognitive decline in PD. Increased P3b latency is linked to disease severity and impaired activities.
- PD patients often show a smaller P3b amplitude in tasks requiring greater attention resources (e.g., random number generation).
- The P3a component is considered a potential cognitive marker for mild to moderate PD.
- ERPs elicited during auditory oddball paradigms may not be suitable as a biomarker for FOG symptoms.
- Other EEG Measures:
- Cortico-muscular coherence (CMC) findings are inconsistent but suggest potential links to motor abnormalities.
- EEG microstates analysis shows promise in differentiating neurodegenerative diseases and may reflect cognitive fluctuations.
- Grand Total EEG (GTE) score has shown a negative correlation with cognitive decline in PD patients, suggesting its potential for identifying mild cognitive impairment (MCI).
Limitations and Future Work
The authors acknowledge several limitations:
- Unclear Mechanisms: The precise underlying mechanisms of the interrelation between gait and cognitive function in PD remain unclear.
- Variability in Studies: Current studies exhibit a variety of sample sizes and experimental settings, leading to some inconsistent conclusions.
- Need for Further Elucidation: A deeper understanding of the specific nature of the relationship between EEG patterns and PD symptoms is essential for developing novel diagnostic and therapeutic methods.
Future work should focus on:
- Elucidating the relative contributions of EEG patterns to reflecting both cognitive and motor symptoms.
- Developing more robust and standardized EEG-based diagnostic and therapeutic approaches.
- Conducting studies with larger sample sizes and more standardized experimental protocols to overcome current inconsistencies.
- Investigating the potential of EEG microstates and other advanced EEG analysis techniques for better characterization of PD.
Summary updated